Indian pharma company Zydus Healthcare Ltd on Wednesday (June 19) responded to reports that Nepal has suspended sale and distribution of one of its injections 'over serious health risks'.

Indian pharma firm says reports of Nepal banning its injection 'misleading, erroneous'

Indian pharmaceutical company Zydus has started human studies for its potential COVID-19 vaccine, as coronavirus infections continue to surge in the world's third worst-hit nation.

India's Zydus begins human trials for potential COVID-19 vaccine

Zydus Healthcare estimates that the market size of the two ANDAs put together is nearly US$ 200 million

Indian pharma company buys 2 ANDAs from US drug maker

zydus-healthcare

Zydus Healthcare, News on Zydus Healthcare, stories on Zydus Healthcare, articles on Zydus Healthcare, Zydus Healthcare stories at Wion, Zydus Healthcare news, Zydus Healthcare latest news

zydus healthcare

Indian pharma firm says reports of Nepal banning its injection 'misleading, erroneous'

India's Zydus begins human trials for potential COVID-19 vaccine

Indian pharma company buys 2 ANDAs from US drug maker